Results 141 to 150 of about 15,932 (195)

Effects of SGLT2 inhibition on incident heart failure in carriers of cardiomyopathy-associated genetic variants. [PDF]

Nat Med
Marston NA, Kany S, Melloni GEM, Jurgens SJ, Kamanu FK, Lai YP, Rämö JT, Raz I, Wiviott SD, Ellinor PT, Sabatine MS, Ruff CT.   +11 more
europepmc   +1 more source

Pluronic F-127/Propylene Glycol Binary Building Blocks for Novel Solid Dispersion Matrix: Industrial and Ecological Paradigm to Enhance Dissolution Profile of Dapagliflozin. [PDF]

Pharmaceutics
Sherif AY, Altamimi MA, Elzayat EM.
europepmc   +1 more source

Direct dapagliflozin exposure enhances respiration and membrane hyperpolarization in isolated cardiac mitochondria. [PDF]

Front Physiol
de Souza IIA, da Rosa CFM, Marinho LE, Coutinho MB, Moraes CDS, de Carvalho ACC, Nascimento JHM, Pinto LMO.   +7 more
europepmc   +1 more source

Real-world evidence with dapagliflozin in heart failure with reduced ejection fraction in Central Eastern Europe and the Baltic region (EVOLUTION-HF CEE-BA Study). [PDF]

ESC Heart Fail
Leszek P, Csanádi Z, Gruev I, Uuetoa T, Žaliaduonytė D, Miličić D, Trušinskis K, Baukienė J, Isvoranu AM, Chioncel O.   +9 more
europepmc   +1 more source

Real-World Experience With Dapagliflozin in Non-diabetic Chronic Kidney Disease: A Case Series From India. [PDF]

Cureus
Pal A, Sadhukhan S.
europepmc   +1 more source

Targeting epicardial adipose tissue in heart failure with preserved ejection fraction: exploring the dapagliflozin connection. [PDF]

BMC Cardiovasc Disord
Soliman AM, Ghaleb R, Mahmoud AH, Heidar MAA, Ibrahim A.   +4 more
europepmc   +1 more source

Dapagliflozin ameliorates motor deficits in a Parkinson's disease model induced by 6-OHDA: An integrative in vivo and in silico approach from α-synuclein/A2AAR/TH/TNF-α to APAF-1/caspase-3 modulation. [PDF]

Inflammopharmacology
Sezen S, Burul F, Okkay U, Karadayı M, Ozkaraca M, Bayram C, Gülşahin Y, Ferah Okkay I, Gulluce M.   +8 more
europepmc   +1 more source

Development and validation of stability indicating RP-HPLC method for the simultaneous estimation of dapagliflozin and eplerenone in bulk and synthetic mixture. [PDF]

BMC Chem
Tandel P, Mehta H.
europepmc   +1 more source

Dapagliflozin attenuates cisplatin-induced nephrotoxicity in rats through modulation of ROS/NF-κB, BCL2/Bax and PINK1/Parkin signaling pathways. [PDF]

Sci Rep
Khallaf EK, Ramadan EA, Elmazar MM, Safar MM.   +3 more
europepmc   +1 more source

Partial restoration of counterregulatory circulating glucagon by dapagliflozin and low-dose glibenclamide in men with type 1 diabetes: in vitro studies and randomised clinical crossover trial. [PDF]

EBioMedicine
Gao R, Spiliotis I, Dou H, Hill TG, Kothegala L, Miranda C, Abiakam N, Coleman RL, White S, Adler A, Rorsman P.   +10 more
europepmc   +1 more source